ClinicalTrials.gg
CompletedNCT05940805Updated Jul 25, 2024

Comprehensive Protocol for Treatment of Upper Limb Spasticity in Post-stroke Hemiplegic Patients

An interventional study of Low-frequency transcranial electrical stimulation; Paraspinous block; Dry needling of spastic upper limb muscles; Muscular functional electrical stimulation (FES) and SHAM Low-frequency transcranial electrical stimulation; Paraspinous block; Dry needling of spastic upper limb muscles; Muscular functional electrical stimulation (FES) in Post-stroke Upper Limb Spasticity, sponsored by University of Sao Paulo General Hospital. Completed at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-25.

Sponsored by University of Sao Paulo General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The general objective of this study was to evaluate the efficacy of the comprehensive protocol in improving post-stroke upper limb spasticity. The specific objectives were to evaluate pain improvement and changes in quality of life and functional capacity in patients who were subjected to the comprehensive protocol compared with those in the patients who underwent sham interventions.

Read the detailed description

Background: Managing post-stroke upper limb spasticity is a major challenge in the rehabilitation field. The objective of this study was to evaluate the efficacy of a comprehensive treatment protocol with four therapeutic modalities in the recovery of patients with chronic stroke by evaluating clinical, neurological and functional outcomes.

Methodology: Thirty-two subjects diagnosed with a stroke at least six months prior to the study were randomized to receive ten sessions of either the treatment protocol or a sham intervention. The treatment protocol consisted of transcranial low-frequency electrical stimulation using subcutaneous needles over the scalp, paraspinous blocks, spastic muscle needling and functional electrical stimulation. Spasticity, range of motion, pain, functionality and quality of life were evaluated.

02

Conditions studied

  • Post-stroke Upper Limb Spasticity

Keywords

  • Muscle Spasticity
  • Stroke
  • Stroke Rehabilitation
  • Nerve Block
  • Dry Needling
  • Transcranial Direct Current Stimulation
  • Electric Stimulation Therapy
03

In context

Muscle Spasticity

713 studies on the registry are indexed under Muscle Spasticity; 148 are open to participants now.

This study's enrollment of 32 is below the median of 36 across 532 interventional studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

University of Sao Paulo General Hospital is the lead sponsor of 608 studies on the registry; 97 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age older than 18 years;
  • Diagnosis of ischemic or hemorrhagic stroke at least six months previously;
  • Presence of single upper limb spasticity

Exclusion criteria

Exclusion Criteria:

  • Spasticity due to conditions other than stroke;
  • Hypersensitivity to lidocaine;
  • Use of cardiac pacemakers;
  • Presence of coagulation disturbances;
  • Insufficient perceptual and cognitive capacity to understand the proposed treatment and answer the questionnaires
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Protocol Group (PG)

    The PG received the following combination of four therapeutic modalities twice a week for five weeks: 1. Low-frequency transcranial electrical stimulation; 2. Paraspinous block; 3. Dry needling of spastic upper limb muscles; 4. Muscular functional electrical stimulation (FES).

    Procedure: Low-frequency transcranial electrical stimulation; Paraspinous block; Dry needling of spastic upper limb muscles; Muscular functional electrical stimulation (FES)

  • Sham comparator
    Sham Group (SG)

    The Sham Group also received the four modalities of the intervention, but these modalities were all inactive. For simulation of transcranial electrical stimulation and FES, electrodes were placed on the scalp and in the upper extremity muscles and were connected to a device similar to the real electric current generator. This device did not transmit any electric current but had blinking lights and produced sound to provide the subjects visual and auditory feedback. To simulate dry needling and paraspinous block, retractile needles were used. The patients were blinded to their assigned treatment group.

    Procedure: SHAM Low-frequency transcranial electrical stimulation; Paraspinous block; Dry needling of spastic upper limb muscles; Muscular functional electrical stimulation (FES)

Interventions

  • ProcedureLow-frequency transcranial electrical stimulation; Paraspinous block; Dry needling of spastic upper limb muscles; Muscular functional electrical stimulation (FES)

    1. Low-frequency transcranial electrical stimulation (2/100 Hz) applied through 0.3-mm-diameter and 40-mm-long needles placed subcutaneously on the scalp at the projection of Penfield's motor homunculus and sensory and frontal supplementary motor associative areas. 2. Paraspinous block at the levels of the C5, C6 and C7 vertebrae concordant with spasticity laterality. 3. Dry needling of spastic upper limb muscles, as identified through a thorough physical examination, using 0.3-mm-diameter and 40-mm-long needles. 4. Muscular functional electrical stimulation (FES) in the antagonists of the upper limb muscles with spasticity with the following parameters: 20-Hz frequency, 300-µs pulse width, zero-second ramp time, 5-second stimulation time, and 5-second resting time.

  • ProcedureSHAM Low-frequency transcranial electrical stimulation; Paraspinous block; Dry needling of spastic upper limb muscles; Muscular functional electrical stimulation (FES)

    For simulation of transcranial electrical stimulation and FES, electrodes were placed on the scalp and in the upper extremity muscles and were connected to a device similar to the real electric current generator. This device did not transmit any electric current but had blinking lights and produced sound to provide the subjects visual and auditory feedback. To simulate dry needling and paraspinous block, retractile needles were used.

06

What researchers measure

Primary outcomes

  1. Modified Ashworth scale

    To measure spasticity, and shoulder, elbow and wrist active and passive goniometry was performed to measure range of motion improvement. Minimum value = 0 (No increase in tone); Maximum value = 4 (Affected part in rigid flexion and extension)

    Time frame: 3 months

  2. Visual analogue scale (VAS)

    To measure patients pain after the interventions. Minimun value = 0 (Painless); Maximum value = 10 (painful)

    Time frame: 3 months

  3. Functional independence measure (FIM)

    To measure independence of patients after the interventions. The Functional Independence Measure (FIM) is a functional assessment with 18 items in the areas of personal care, sphincter control, mobility, communication and social-cognition, through a broad questionnaire. Minimun value = 18 (total dependence); maximum value = 126 (total independence)

    Time frame: 3 months

  4. Quality of Life - SF-36 questionnaire

    To measure patients' quality of life after the interventions for each domain. Minimum value (for each domain) = 0 (bad quality of life); Maximum value for each domain = 100 (good quality of life)

    Time frame: 3 months

07

Study locations

1 site
  • University of São Paulo General Hospital
    São Paulo, 05403010, Brazil
08

References and documents

Publications

  • Treger I, Shames J, Giaquinto S, Ring H. Return to work in stroke patients. Disabil Rehabil. 2007 Sep 15;29(17):1397-403. doi: 10.1080/09638280701314923. PubMed 17729085 ↗
  • Ovbiagele B, Nguyen-Huynh MN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 2011 Jul;8(3):319-29. doi: 10.1007/s13311-011-0053-1. PubMed 21691873 ↗
  • Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3;125(1):188-97. doi: 10.1161/CIR.0b013e3182456d46. No abstract available. PubMed 22215894 ↗
  • Ones K, Yilmaz E, Cetinkaya B, Caglar N. Quality of life for patients poststroke and the factors affecting it. J Stroke Cerebrovasc Dis. 2005 Nov-Dec;14(6):261-6. doi: 10.1016/j.jstrokecerebrovasdis.2005.07.003. PubMed 17904035 ↗
  • Burke D, Wissel J, Donnan GA. Pathophysiology of spasticity in stroke. Neurology. 2013 Jan 15;80(3 Suppl 2):S20-6. doi: 10.1212/WNL.0b013e31827624a7. PubMed 23319482 ↗
  • Sunnerhagen KS, Olver J, Francisco GE. Assessing and treating functional impairment in poststroke spasticity. Neurology. 2013 Jan 15;80(3 Suppl 2):S35-44. doi: 10.1212/WNL.0b013e3182764aa2. PubMed 23319484 ↗
  • Schlaug G, Renga V, Nair D. Transcranial direct current stimulation in stroke recovery. Arch Neurol. 2008 Dec;65(12):1571-6. doi: 10.1001/archneur.65.12.1571. PubMed 19064743 ↗
  • Bhakta BB. Management of spasticity in stroke. Br Med Bull. 2000;56(2):476-85. doi: 10.1258/0007142001903111. PubMed 11092096 ↗
  • Gerwin RD. Myofascial pain and fibromyalgia: Diagnosis and treatment. J Back Musculoskelet Rehabil. 1998 Jan 1;11(3):175-81. doi: 10.3233/BMR-1998-11304. PubMed 24572598 ↗
  • Teasell RW, Foley NC, Bhogal SK, Speechley MR. An evidence-based review of stroke rehabilitation. Top Stroke Rehabil. 2003 Spring;10(1):29-58. doi: 10.1310/8YNA-1YHK-YMHB-XTE1. PubMed 12970830 ↗
  • Raju RS, Sarma PS, Pandian JD. Psychosocial problems, quality of life, and functional independence among Indian stroke survivors. Stroke. 2010 Dec;41(12):2932-7. doi: 10.1161/STROKEAHA.110.596817. Epub 2010 Oct 21. PubMed 20966411 ↗
  • Boyaci A, Topuz O, Alkan H, Ozgen M, Sarsan A, Yildiz N, Ardic F. Comparison of the effectiveness of active and passive neuromuscular electrical stimulation of hemiplegic upper extremities: a randomized, controlled trial. Int J Rehabil Res. 2013 Dec;36(4):315-22. doi: 10.1097/MRR.0b013e328360e541. PubMed 23579106 ↗
  • de Kroon JR, IJzerman MJ. Electrical stimulation of the upper extremity in stroke: cyclic versus EMG-triggered stimulation. Clin Rehabil. 2008 Aug;22(8):690-7. doi: 10.1177/0269215508088984. PubMed 18678569 ↗
  • Hara Y, Ogawa S, Muraoka Y. Hybrid power-assisted functional electrical stimulation to improve hemiparetic upper-extremity function. Am J Phys Med Rehabil. 2006 Dec;85(12):977-85. doi: 10.1097/01.phm.0000247853.61055.f8. PubMed 17117002 ↗
  • Wu D, Qian L, Zorowitz RD, Zhang L, Qu Y, Yuan Y. Effects on decreasing upper-limb poststroke muscle tone using transcranial direct current stimulation: a randomized sham-controlled study. Arch Phys Med Rehabil. 2013 Jan;94(1):1-8. doi: 10.1016/j.apmr.2012.07.022. Epub 2012 Aug 7. PubMed 22878231 ↗
  • Hara Y, Ogawa S, Tsujiuchi K, Muraoka Y. A home-based rehabilitation program for the hemiplegic upper extremity by power-assisted functional electrical stimulation. Disabil Rehabil. 2008;30(4):296-304. doi: 10.1080/09638280701265539. PubMed 17852312 ↗
  • Sahin N, Ugurlu H, Albayrak I. The efficacy of electrical stimulation in reducing the post-stroke spasticity: a randomized controlled study. Disabil Rehabil. 2012;34(2):151-6. doi: 10.3109/09638288.2011.593679. Epub 2011 Oct 15. PubMed 21999668 ↗
  • Ring H, Weingarden H. Neuromodulation by functional electrical stimulation (FES) of limb paralysis after stroke. Acta Neurochir Suppl. 2007;97(Pt 1):375-80. doi: 10.1007/978-3-211-33079-1_49. PubMed 17691399 ↗
  • Popovic DB, Popovic MB, Sinkjaer T. Neurorehabilitation of upper extremities in humans with sensory-motor impairment. Neuromodulation. 2002 Jan;5(1):54-66. doi: 10.1046/j.1525-1403.2002._2009.x. PubMed 22151782 ↗
  • Bergfeldt U, Skold C, Julin P. Short Form 36 assessed health-related quality of life after focal spasticity therapy. J Rehabil Med. 2009 Mar;41(4):279-81. doi: 10.2340/16501977-0318. PubMed 19247549 ↗
  • Childers MK, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D, Walcott JM, Jenkins SW, Turkel C, Molloy PT. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil. 2004 Jul;85(7):1063-9. doi: 10.1016/j.apmr.2003.10.015. PubMed 15241751 ↗
  • Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000 Aug;53(8):786-92. doi: 10.1016/s0895-4356(00)00206-7. PubMed 10942860 ↗
  • Ratmansky M, Defrin R, Soroker N. A randomized controlled study of segmental neuromyotherapy for post-stroke hemiplegic shoulder pain. J Rehabil Med. 2012 Oct;44(10):830-6. doi: 10.2340/16501977-1021. PubMed 22949162 ↗
  • Cournan M. Use of the functional independence measure for outcomes measurement in acute inpatient rehabilitation. Rehabil Nurs. 2011 May-Jun;36(3):111-7. doi: 10.1002/j.2048-7940.2011.tb00075.x. PubMed 21675396 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05940805
Responsible party
Wu Tu Hsing (Director of Center of Acupuncture of Orthopaedics and Traumatology Institute, University of Sao Paulo General Hospital) — Principal investigator
First posted
Jul 11, 2023
Start date
Aug 3, 2023
Primary completion
Nov 12, 2023
Completion
Dec 3, 2023
Last update
Jul 25, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion